ASX 300

Seven fund managers walked into a sell-off and came out with a shopping list. Here are the 16 stocks they're backing.

As investors pile into AI, Alvia’s Chris Scarpato is running for the hills and building an anti-AI playbook. Here’s why.

Amidst the macro turmoil, there are several pockets of opportunities for ASX investors. Are you paying attention?

Why Australia's biggest energy bet may already be redundant.

Geopolitical shocks are no longer rare. Three fund managers explain how to position portfolios as uncertainty becomes the baseline.

Core Lithium and Bill Beament’s Develop among those looking to cash in; Plus, Solstice’s growing WA copper find is a winner for shareholders

Livewire's Carl Capolingua and Chris Conway have built a process for identifying growth stocks - they put it into practice here.

The market is not as 'expensive' at it seems at face value, but there is risk, tangible and significant, from profit warnings.

The record share price for the Big Australian looks justifiable as ex-CEO Mike Henry's copper and potash vision starts to bear fruit

The veteran adviser discusses the current setup in growth and software - and three names he’s been waiting to buy at better value.

When markets swing wildly, fundamentals take over. Jun Bei Liu and Oscar Oberg share the stocks and strategy guiding their portfolios.

The world must now maintain the fossil fuel system it depends on while building an entirely different energy architecture alongside it.

Five ASX stocks that have defied the gloom. IML's Lucas Goode and Hayborough's Ben Rundle weigh in on whether the rally has further to run.

How passive investing has permanently changed market structure — and why sophisticated tools are now the price of survival

A Strait of Hormuz closure is not just an oil story. What it means for commodities, inflation, and Australian investors.

Portfolio manager Andrew Martin on how the firm finds stocks with genuine earnings momentum.

IML's Lucas Goode and Ben Rundle of Hayborough on who the genuine innovators are worth backing in a volatile market.

Morningstar sees broad undervaluation across the market – and highlights where to look for opportunities.

Market scepticism masks opportunity. Collins Foods combines proven Aussie returns with emerging German growth optionality.

Your brain lies to you about prices, and it's probably costing you money!

Are dividends making Australians worse investors?

Stocks are back at record highs. Is the rally real, or are markets sleepwalking into another crash? What you need to know before you invest.

We believe the market underappreciates the strategic value of their Lytton refinery asset.